Role of Canagliflozin on gene expression and function of CD34+ endothelial progenitor cells in patients with type 2 diabetes and mild chronic kidney disease (Stages 1-2, CKD)

We are looking to see if Invokana, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin (1000-2000mg). Your HbA1C should be between 7 – 10 %.

Primary Sponsor:
Janssen Pharmaceuticals, Inc.

Prinicipal Investigator:
Sabyasachi Sen, MD/Endocrinology

Contact Phone:
202-741-2342

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
     
Verification Code *

Please type what you see (all uppercase):